Dysregulation of core components of SCF complex in poly-glutamine disorders

Cell Death and Disease

Volumn 3, Issue 11, 2012, Pages

  Bhutani, S ^a   Das, A ^a   Maheshwari, M ^a   Lakhotia, S C ^b   Jana, N R ^a  

^a NATIONAL BRAIN RESEARCH CENTRE   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Cullin1; E3 ligase; Huntington's disease; Neurodegeneration; SCF

Indexed keywords

HUNTINGTIN; POLYGLUTAMINE; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA MODIFICATION; DROSOPHILA; FEMALE; GENE SILENCING; HUNTINGTON CHOREA; MACHADO JOSEPH DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REDUCTION;

ANIMALS; CULLIN PROTEINS; DROSOPHILA; FEMALE; HUMANS; HUNTINGTON DISEASE; MACHADO-JOSEPH DISEASE; MALE; MICE; MICE, TRANSGENIC; PEPTIDES; SKP CULLIN F-BOX PROTEIN LIGASES;

MUS;

EID: 84870498174     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.166     Document Type: Article

References (45)

1. MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993; 72: 971-983.
2. Rubinsztein DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassiman JJ et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996; 59: 16-22.
3. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 1994; 8: 221-228.
4. Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 2003; 4: 49-60.
5. Ross CA, Tabrizi SJ. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011; 10: 83-98.
6. Jackson GR, Salecker I, Dong X, Yao X, Arnheim N, Faber PW et al. Polyglutamineexpanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 1998; 21: 633-642.
7. Mallik M, Lakhotia SC. Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models. J Genet 2010; 89: 497-526.
8. Wang GH, Mitsui K, Kotliarova S, Yamashita A, Nagao Y, Tokuhiro S et al. Caspase activation during apoptotic cell death induced by expanded polyglutamine in N2a cells. Neuroreport 1999; 10: 2435-2438.
9. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87: 493-506.
10. Lehman NL. The ubiquitin proteasome system in neuropathology. Acta Neuropathol 2009; 118: 329-347.
11. Jana NR, Zemskov EA, Wang G, Nukina N. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum Mol Genet 2001; 10: 1049-1059.
12. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605-608.
13. Cummings CJ, Reinstein E, Sun Y, Antalffy B, Jiang Y, Ciechanover A et al. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 1999; 24: 879-892.
14. Maheshwari M, Samanta A, Godavarthi SK, Mukherjee R, Jana NR. Dysfunction of the ubiquitin ligase ube3a may be associated with synaptic pathophysiology in a mouse model of huntington disease. J Biol Chem 2012; 287: 29949-29957.
15. Mishra A, Dikshit P, Purkayastha S, Sharma J, Nukina N, Jana NR. E6-AP promotes misfolded polyglutamine proteins for proteasomal degradation and suppresses polyglutamine protein aggregation and toxicity. J Biol Chem 2008; 283: 7648-7656.
16. Jana NR, Dikshit P, Goswami A, Kotliarova S, Murata S, Tanaka K et al. Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes. J Biol Chem 2005; 280: 11635-11640.
17. Tsai YC, Fishman PS, Thakor NV, Oyler GA. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J Biol Chem 2003; 278: 22044-22055.
18. Skowyra D, Craig KL, Tyers M, Elledge SJ, Harper JW. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 1997; 91: 209-219.
19. Latres E, Chiaur DS, Pagano M. The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin. Oncogene 1999; 18: 849-854.
20. Hori T, Osaka F, Chiba T, Miyamoto C, Okabayashi K, Shimbara N et al. Covalent modification of all members of human cullin family proteins by NEDD8. Oncogene 1999; 18: 6829-6834.
21. Skaar JR, Pagano M. Control of cell growth by the SCF and APC/C ubiquitin ligases. Curr Opin Cell Biol 2009; 21: 816-824.
22. Uro-Coste E, Fonta C, Hatey F, Perret E, Delisle MB, Caput D et al. Expression of SKP1 mRNA and protein in rat brain during postnatal development. Neuroreport 1997; 8: 1675-1678.
23. Michel JJ, Xiong Y. Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A. Cell Growth Differ 1998; 9: 435-449.
24. Staropoli JF, Abeliovich A. The ubiquitin-proteasome pathway is necessary for maintenance of the postmitotic status of neurons. J Mol Neurosci 2005; 27: 175-183.
25. Fishman-Jacob T, Reznichenko L, Youdim MB, Mandel SA. A sporadic Parkinson disease model via silencing of the ubiquitin-proteasome/E3 ligase component SKP1A. J Biol Chem 2009; 284: 32835-32845.
26. Fishman-Jacob T, Youdim MB, Mandel SA. Silencing/overexpressing selected genes as a model of sporadic Parkinson's disease. Neurodegener Dis 2010; 7: 108-111.
27. Mandel SA, Fishman-Jacob T, Youdim MB. Targeting Skp1, an ubiquitin E3 ligase component found decreased in sporadic Parkinson's disease. Neurodegener Dis 2011; 10: 220-223.
28. Mandel SA, Fishman-Jacob T, Youdim MB. Genetic reduction of the E3 ubiquitin ligase element, SKP1A and environmental manipulation to emulate cardinal features of Parkinson's disease. Parkinsonism Relat Disord 2012; 18(Suppl 1): S177-S179.
29. Doumanis J, Wada K, Kino Y, Moore AW, Nukina N. RNAi screening in Drosophila cells identifies new modifiers of mutant huntingtin aggregation. PLoS One 2009; 4: e7275.
30. Zhang S, Binari R, Zhou R, Perrimon N. A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 2010; 184: 1165-1179.
31. Heriche JK, Ang D, Bier E, O'Farrell PH. Involvement of an SCFSlmb complex in timely elimination of E2F upon initiation of DNA replication in Drosophila. BMC Genet 2003; 4: 9.
32. Voigt J, Chen JA, Gilchrist M, Amaya E, Papalopulu N. Expression cloning screening of a unique and full-length set of cDNA clones is an efficient method for identifying genes involved in Xenopus neurogenesis. Mech Dev 2005; 122: 289-306.
33. Mallik M, Lakhotia SC. The developmentally active and stress-inducible noncoding hsromega gene is a novel regulator of apoptosis in Drosophila. Genetics 2009; 183: 831-852.
34. Warrick JM, Paulson HL, Gray-Board GL, Bui QT, Fischbeck KH, Pittman RN et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 1998; 93: 939-949.
35. Ou CY, Lin YF, Chen YJ, Chien CT. Distinct protein degradation mechanisms mediated by Cul1 and Cul3 controlling Ci stability in Drosophila eye development. Genes Dev 2002; 16: 2403-2414.
36. Riley BE, Orr HT. Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle. Genes Dev 2006; 20: 2183-2192.
37. Yen HC, Elledge SJ. Identification of SCF ubiquitin ligase substrates by global protein stability profiling. Science 2008; 322: 923-929.
38. Copani A, Uberti D, Sortino MA, Bruno V, Nicoletti F, Memo M. Activation of cell-cycleassociated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci 2001; 24: 25-31.
39. Godin JD, Poizat G, Hickey MA, Maschat F, Humbert S. Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease. EMBO J 2010; 29: 2433-2445.
40. Mori F, Nishie M, Piao YS, Kito K, Kamitani T, Takahashi H et al. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders. Neuropathol Appl Neurobiol 2005; 31: 53-61.
41. Dil Kuazi A, Kito K, Abe Y, Shin RW, Kamitani T, Ueda N. NEDD8 protein is involved in ubiquitinated inclusion bodies. J Pathol 2003; 199: 259-266.
42. Mehta R, Steinkraus KA, Sutphin GL, Ramos FJ, Shamieh LS, Huh A et al. Proteasomal regulation of the hypoxic response modulates aging in C. elegans. Science 2009; 324: 1196-1198.
43. Mishra A, Godavarthi SK, Maheshwari M, Goswami A, Jana NR. The ubiquitin ligase E6-AP is induced and recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of Hsp70-bound misfolded proteins. J Biol Chem 2009; 284: 10537-10545.
44. Zhou D, Xue J, Chen J, Morcillo P, Lambert JD, White KP et al. Experimental selection for Drosophila survival in extremely low O(2) environment. PLoS One 2007; 2: e490.
45. Fujikake N, Nagai Y, Popiel HA, Okamoto Y, Yamaguchi M, Toda T. Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones. J Biol Chem 2008; 283: 26188-26197.